Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Tanespimycin

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Tanespimycin 17-AAG HSP90 Chaperone protein folding Phase 1, 2 Sigma-Aldrich A8476

Cell Line (34)
Cell LineAUCGI50
JHH50.410.032
HepG20.450.047
PLC.PRF50.530.078
Huh70.570.106
HCC.1.10.580.17
JHH70.590.19
HCC.1.20.590.14
Huh10.620.21
HLF0.630.285
HLE0.650.25
SNU8780.670.623
SNU3980.670.71
SNU3540.71.005
Li70.70.75
SNU3680.735.89


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it